Home > Products > Active Pharmaceutical Ingredient (API)

Sinae Active Pharmaceutical Ingredient (API) fabrica, supplementum, Factory

View as  
 
Tofacitinib Citrate API

Tofacitinib Citrate API

Tofacitinib Citrate API est medicamento arthritis rheumatoidei, arthritis psoriatic medicamentum, spondylitis medicamento ankylosing, polyarticularis utique pharmacum arthritis juvenile idiopathicum, medicamentum ulcerativi colitis.

Lege plusMitte Inquisitionem
6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione essentialis hypertensionis medicamento eft.

Lege plusMitte Inquisitionem
6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione Hydrochloridis

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione Hydrochloridis

6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione hydrochloridis essentialis hypertensionis medicamento eft.

Lege plusMitte Inquisitionem
CAS NO.64887-14-5

CAS NO.64887-14-5

CAS NO.64887-14-5 est medicamento essentialis hypertensionis.

Lege plusMitte Inquisitionem
CAS 64887-14-5

CAS 64887-14-5

CAS 64887-14-5 medicamentum essentiale est hypertensionis.

Lege plusMitte Inquisitionem
64887-14-5

64887-14-5

64887-14-5 medicamento essentiali hypertensio est.

Lege plusMitte Inquisitionem
<...89101112...14>
Quiescere potes ex officina nostra emere Active Pharmaceutical Ingredient (API) in Sinis. Pharmaceutical Run'an professionalis Sinarum Active Pharmaceutical Ingredient (API) fabrica et supplementum, qualitas products alta praebere possumus. Grata res emendas ex officina nostra.
X
Crusulis utimur ut meliorem experientiam pasco tibi praebeamus, situm negotiationis et personalize contentus analyse. Hoc situ utendo, ad nostrum crustulorum usum consentis. Privacy Policy
Reject Accipe